Flumazenil-precipitated withdrawal in healthy volunteers following repeated diazepam exposure

Psychopharmacology

Volumn 178, Issue 2-3, 2005, Pages 259-267

  Mintzer, Miriam Z ^a   Griffiths, Roland R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE; DIAZEPAM; FLUMAZENIL; NORDAZEPAM; PLACEBO;

ADULT; ANOREXIA; ARTICLE; BLOOD PRESSURE MONITORING; CONFUSION; CONTROLLED STUDY; DIZZINESS; DRUG EXPOSURE; FATIGUE; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; MALE; MENTAL STRESS; MUSCLE WEAKNESS; NORMAL HUMAN; PRIORITY JOURNAL; RESTLESSNESS; RIGIDITY; SIDE EFFECT; SKIN TEMPERATURE; SWEATING; VISUAL IMPAIRMENT; WITHDRAWAL SYNDROME;

ADMINISTRATION, ORAL; ADULT; BLOOD PRESSURE; DIAZEPAM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUMAZENIL; GABA MODULATORS; HUMANS; HYPNOTICS AND SEDATIVES; INJECTIONS, INTRAVENOUS; MALE; SKIN TEMPERATURE; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 15044351604     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-004-2009-1     Document Type: Article

References (44)

1. Bernik MA, Gorenstein C, Gentil V (1991) Flumazenil-precipitated withdrawal symptoms in chronic users of therapeutic doses of diazepam. J Psychopharmacol 5:215-219
2. Bernik MA, Gorenstein C, Vieira Filho AH (1998) Stressful reactions and panic attacks induced by flumazenil in chronic benzodiazepine users. J Psychopharmacol 12:146-150
3. Brogden RN, Goa KL (1991) Flumazenil. A reappraisal of its pharmacodynamic properties and therapeutic efficacy as a benzodiazepine antagonist. Drugs 42:1061-1089
4. Bruce SE, Vasile RG, Goisman RM, Salzman C, Spencer M, Machan JT, Keller MB (2003) Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia? Am J Psychiatry 160:1432-1438
5. Busto UE, Sykora K, Sellers, EM (1989) A clinical scale to assess benzodiazepine withdrawal. J Clin Psychopharmacol 9:412-416
6. Frey JM, Rush CR, Griffiths RR (1996) Physiological, behavioral and subjective effects of flumazenil-precipitated withdrawal in benzodiazepine- dependent methadone clients. Poster presented at the annual meeting of the Society for Neuroscience, Washington, DC
7. Gallager DW, Heninger K, Heninger G (1986) Periodic benzodiazepine antagonist administration prevents benzodiazepine withdrawal symptoms in primates. Eur J Pharmacol 132:31-38
8. Gerra G, Marcato A, Caccavari R, Fertonani-Affmi G, Fontanesi B, Zaimovic A, Avanzini P, Delsignore R (1993) Effectiveness of flumazenil (RO 15-1788) in the treatment of benzodiazepine withdrawal. Curr Ther Res Clin Exp 54:580-587
9. Gerra G, Giucasto G, Zaimovic A, Fertonani G, Chittolini B, Avanzini P, Caccavari R, Delsignore R (1996) Intravenous flumazenil following prolonged exposure to lormetazepam in humans: lack of precipitated withdrawal. Int Clin Psychopharmacol 11:81-88
10. Greenblatt DJ, Laughren TP, Allen MD, Harmatz JS, Shader RI (1981) Plasma diazepam and desmethyldiazepam concentrations during long-term diazepam therapy. Br J Clin Pharmacol 1:35-40
11. Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals-implications for problems of long-term use and abuse. Psychopharmacology (Berl) 134:1-37
12. Griffiths RR, Evans SM, Guarino JJ, Roache JD, Furman WR, Liebson I, Schwam EM (1993) Intravenous flumazenil following acute and repeated exposure to lorazepam in healthy volunteers: antagonism and precipitated withdrawal. J Pharmacol Exp Ther 265:1163-1174
13. Harrison-Read PE, Tyrer P, Lawson C, Lack S, Femandes C, File SE (1996) Flumazenil-precipitated panic and dysphoria in patients dependent on benzodiazepines: a possible aid to abstinence. J Psychopharmacol 10:89-97
14. IMS Health (2003) Available from http://www.imshealth.com/ims/portal/ front/articleC/O,2777,6599_42720951_43989693,00.html, accessed 2003
15. Kaminski BJ, Sannerud CA, Weerts EM, Lamb RJ, Griffiths RR (2003) Physical dependence in baboons chronically treated with low and high doses of diazepam. Behav Pharmacol 14:331-342
16. Kaufman DW, Kelly JP, Rosenberg L, Anderson TE, Mitchell AA (2002) Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey. JAMA 287:337-344
17. Keppel G (1991) Design and analysis: a researcher's handbook, 3rd edn. Prentice Hall, Englewood Cliffs
18. Lader MH, Morton SV (1992) A pilot study of the effects of flumazenil on symptoms persisting after benzodiazepine withdrawal. J Psychopharmacol 6:357-363
19. Lamb RJ, Griffiths RR (1985) Effects of repeated Ro 15-1788 administration in benzodiazepine-dependent baboons. Eur J Pharmacol 110:257-261
20. Lamb RJ, Griffiths RR (1987) Effects of Ro 15-1788 and CGS 8216 in diazepam-dependent baboons. Eur J Pharmacol 143:205-212
21. Lukas SE, Griffiths RR (1982) Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15-1788) after 7 days of diazepam. Science 217:1161-1163
22. Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of exposure. Eur J Pharmacol 100:163-171
23. Martin WR, Sloan JW, Wala E (1990) Precipitated abstinence in orally dosed benzodiazepine-dependent dogs. J Pharmacol Exp Ther 255:744-755
24. McNicholas LF, Martin WR (1982) The effect of a benzodiazepine antagonist, RO15-1788, in diazepam dependent rats. Life Sci 31:731-737
25. McNicholas LF, Martin WR, Sloan JW, Wala E (1988) Precipitation of abstinence in nordiazepam- and diazepam-dependent dogs. J Pharmacol Exp Ther 245:221-224
26. Mintzer MZ, Stoller KB, Griffiths RR (1999) A controlled study of flumazenil-precipitated withdrawal in chronic low-dose benzodiazepine users. Psychopharmacology 147:200-209
27. Nutt DJ (1990) Pharmacological mechanisms of benzodiazepine withdrawal. J Psychiatr Res 24(Suppl 2): 105-110
28. Nutt DJ, Glue P, Lawson C, Wilson S (1990) Flumazenil provocation of panic attacks. Arch Gen Psychiatry 47:917-925
29. Petursson H, Lader M (1984) Dependence on tranquilizers, Maudsley monographs 28. Oxford University Press, Oxford
30. Physicians' Desk Reference (2003) 57th edn. Medical Economics, Montvale
31. Rosenberg HC, Chiu TH (1985) Time course for development of benzodiazepine tolerance and physical dependence. Neurosci Biobehav Rev 9:123-131
32. Sannerud CA, Cook JM, Griffiths RR (1989) Behavioral differentiation of benzodiazepine ligands after repeated administration in baboons. Eur J Pharmacol 167:333-343
33. Sannerud CA, Allen M, Cook JM, Griffiths RR (1991) Behavioral effects of benzodiazepine ligands in non-dependent, diazepamdependent and diazepam-withdrawn baboons. Eur J Pharmacol 202:159-169
34. Savic I, Widen L, Stone-Elander S (1991) Feasibility of reversing benzodiazepine tolerance with flumazenil. Lancet 337:133-137
35. Saxon L, Hjemdahl P, Hiltunen AJ, Borg S (1997) Effects of flumazenil in the treatment of benzodiazepine withdrawal - a double-blind pilot study. Psychopharmacology (Berl) 131:153-160
36. Scherkl R, Frey HH (1986) Physical dependence on clonazepam in dogs. Pharmacology 32:18-24
37. Sloan JW, Martin WR, Wala E (1991a) Duration of diazepam (DZ) treatment and the intensity of flumazenil precipitated abstinence (FPA) in dogs. FASEB J 5:A703
38. Sloan JW, Martin WR, Wala E, Dickey KM (1991b) Chronic administration of and dependence on halazepam, diazepam, and nordiazepam in the dog. Drug Alcohol Depend 28:249-264
39. Sloan JW, Martin WR, Wala E (1993) Effect of the chronic dose of diazepam on the intensity and characteristics of the precipitated abstinence syndrome in the dog. J Pharmacol Exp Ther 265:1152-1162
40. Spielberger CD, Gorsuch RL, Lushene RE (1970) STAI manual for the state-trait anxiety inventory ("Self-Evaluation Questionnaire"). Consulting Psychologists, Palo Alto
41. Wilson MA, Gallager DW (1988) Ro 15-1788-induced seizures in rats continually exposed to diazepam for prolonged periods. Epilepsy Res 2:14-19
42. Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Pharmacol Rev 39:251-419
43. Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151-347
44. Zharkovskii AM, Zharkovskaia TA (1987) Characteristics of the abstinence syndrome induced by the administration of the benzodiazepine antagonist CGS 8216 to rats following chronic treatment with diazepam. Biull Eksp Biol Med 104:318-321